United Kingdom · Question · Written question
UIN 3633
Cystic Fibrosis: Drugs
Introduced
24 November 2023
Last action
30 November 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
30 November 2023
Summary
To ask the Secretary of State for Health and Social Care, whether a child suffering from cystic fibrosis who is currently taking Orkambi will be able to move on to taking Kaftrio if their clinician considers it more effective once current NICE recommenda
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
24 November 2023
Written question
To ask the Secretary of State for Health and Social Care, whether a child suffering from cystic fibrosis who is currently taking Orkambi will be able to move on to taking Kaftrio if their clinician considers it more effective once current NICE recommenda
Source: Commons
30 November 2023
Answer
The commercial deal NHS England reached with Vertex covers their entire portfolio of licensed cystic fibrosis treatments. NHS England’s continued expectation in implementing the agreement is that Vertex will enable any patients already initiated on any of...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-11-24/3633
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1672813
- uk · wq-1672813 · source updated 30 November 2023